Van der Auwera P[au] - Search Results

Year	Number of Results
1982	2
1983	6
1984	3
1985	10
1986	14
1987	12
1988	14
1989	13
1990	15
1991	10
1992	6
1993	8
1994	3
1995	1
1996	2
2001	2
2002	1
2003	2
2018	1
2019	1
2020	2
2026	0

1

RPamide neuropeptides NLP-22 and NLP-2 act through GnRH-like receptors to promote sleep and wakefulness in C. elegans.

Van der Auwera P, Frooninckx L, Buscemi K, Vance RT, Watteyne J, Mirabeau O, Temmerman L, De Haes W, Fancsalszky L, Gottschalk A, Raizen DM, Nelson MD, Schoofs L, Beets I. Van der Auwera P, et al. Sci Rep. 2020 Jun 18;10(1):9929. doi: 10.1038/s41598-020-66536-2. Sci Rep. 2020. PMID: 32555288 Free PMC article.

2

Neuromedin U signaling regulates retrieval of learned salt avoidance in a C. elegans gustatory circuit.

Watteyne J, Peymen K, Van der Auwera P, Borghgraef C, Vandewyer E, Van Damme S, Rutten I, Lammertyn J, Jelier R, Schoofs L, Beets I. Watteyne J, et al. Among authors: van der auwera p. Nat Commun. 2020 Apr 29;11(1):2076. doi: 10.1038/s41467-020-15964-9. Nat Commun. 2020. PMID: 32350283 Free PMC article.

3

A GABAergic and peptidergic sleep neuron as a locomotion stop neuron with compartmentalized Ca2+ dynamics.

Steuer Costa W, Van der Auwera P, Glock C, Liewald JF, Bach M, Schüler C, Wabnig S, Oranth A, Masurat F, Bringmann H, Schoofs L, Stelzer EHK, Fischer SC, Gottschalk A. Steuer Costa W, et al. Among authors: van der auwera p. Nat Commun. 2019 Sep 10;10(1):4095. doi: 10.1038/s41467-019-12098-5. Nat Commun. 2019. PMID: 31506439 Free PMC article.

4

Functionally asymmetric motor neurons contribute to coordinating locomotion of Caenorhabditis elegans.

Tolstenkov O, Van der Auwera P, Steuer Costa W, Bazhanova O, Gemeinhardt TM, Bergs AC, Gottschalk A. Tolstenkov O, et al. Among authors: van der auwera p. Elife. 2018 Sep 11;7:e34997. doi: 10.7554/eLife.34997. Elife. 2018. PMID: 30204083 Free PMC article.

5

Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.

Furst DE, Weisman M, Paulus HE, Bulpitt K, Weinblatt M, Polisson R, Zaug M, Kneer J, Van der Auwera P, Stevens RM. Furst DE, et al. Among authors: van der auwera p. J Rheumatol. 2003 Oct;30(10):2123-6. J Rheumatol. 2003. PMID: 14528504 Clinical Trial.

6

Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.

Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, Kneer J, van der Auwera P, Stevens RM; Rheumatology Group 791. Rau R, et al. Among authors: van der auwera p. J Rheumatol. 2003 Apr;30(4):680-90. J Rheumatol. 2003. PMID: 12672184 Clinical Trial.

7

Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients.

Viens P, Chabannon C, Pouillard P, Janvier M, Brugger W, Blay JY, Oberling F, Capdeville R, Newman C, Méresse V, Xu ZX, Platzer E, Van der Auwera P, Maraninchi D. Viens P, et al. Among authors: van der auwera p. J Clin Oncol. 2002 Jan 1;20(1):24-36. doi: 10.1200/JCO.2002.20.1.24. J Clin Oncol. 2002. PMID: 11773150 Clinical Trial.

8

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P; Lenercept Study Group. Abraham E, et al. Among authors: van der auwera p. Crit Care Med. 2001 Mar;29(3):503-10. doi: 10.1097/00003246-200103000-00006. Crit Care Med. 2001. PMID: 11373411 Clinical Trial.

9

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.

van Der Auwera P, Platzer E, Xu ZX, Schulz R, Feugeas O, Capdeville R, Edwards DJ. van Der Auwera P, et al. Am J Hematol. 2001 Apr;66(4):245-51. doi: 10.1002/ajh.1052. Am J Hematol. 2001. PMID: 11279634 Free article. Clinical Trial.

10

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci.

Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Van der Auwera P, et al. J Infect Dis. 1996 May;173(5):1129-36. doi: 10.1093/infdis/173.5.1129. J Infect Dis. 1996. PMID: 8627064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year